Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 8 EP applications Anna Harrison has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14166504

Methods for administering anti-IL-5 antibodies

IPC classification:
A61K 38/10
Applicant:
GlaxoSmithKline LLC
Agent:
Anna Harrison, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13727643

POLYPEPTIDE LOADED POCA NANOPARTICLES FOR ORAL ADMINISTRATION

IPC classification:
A61K 38/26, A61K 38/22, A61K 9/51
Applicant:
Glaxo Group Limited
Agent:
Anna Harrison, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP17159323

PRODUCTION METHOD

IPC classification:
C12N 15/85, C12N 7/02, C12P 21/02, C07K 16/00, C12N 15/67, C07K 16/18
Applicant:
Glaxo Group Limited
Agent:
Anna Harrison, GlaxoSmithKline
Status:
Request for examination was made
EP16757728

COMBINATION TREATMENTS AND USES AND METHODS THEREOF

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/28
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Anna Harrison, GlaxoSmithKline
Status:
Request for examination was made
EP16729070

TLR4 AGONISTS AND COMPOSITIONS THEREOF AND THEIR USE IN THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/7032, A61K 31/675, A61K 31/407, A61K 45/06
Agent:
Anna Harrison, GlaxoSmithKline
Status:
Request for examination was made
EP16729378

COMBINATIONS OF AN OX40 ANTIBODY AND A TLR4 MODULATOR AND USES THEREOF

IPC classification:
C07K 16/28, A61K 31/7008, A61K 39/395
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Anna Harrison, GlaxoSmithKline
Status:
Request for examination was made
EP16757350

COMBINATION TREATMENTS AND USES AND METHODS THEREOF

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Anna Harrison, GlaxoSmithKline
Status:
Request for examination was made
EP16757353

COMBINATION TREATMENTS AND USES AND METHODS THEREOF

IPC classification:
C07K 16/28
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Anna Harrison, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature